Effects of supplementation with vitamin D in patients with chronic kidney disease

Not Applicable

• Conditions: Vitamin D deficiency, Chronic kidney failure.; C18.654.521.500.133.770; C12.777.419.780.750.500

• Registration Number: RBR-95j5pm
• Lead Sponsor: niversidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients in stages 3 and 4 CKD (creatinine clearance between 59 and 15 mL/min/1.73m ²); Both genders; Aged between 18 and 75 years; Patients in the conservative treatment of CKD for at least 3 months; With serum 25 (OH) D3 <30 ng/mL: And who agree to participate.

Exclusion Criteria

Patients with nephrotic syndrome, liver disease, neoplastic, autoimmune or infectious activity and were seropositive for HIV;
Patients who received any supplements or vitamin D analogues, corticosteroids and immunosuppressive drugs in the last 3 months;
Patients with hypercalcemia (ionized calcium> 1.40 mmol/L) and/or serum parathormone (PTH) levels> 500 pg/mL; Patients immobilized in the last three months.

Study & Design

• Study Type: Intervention
• Study Design: Not specified